Picture of Corbus Pharmaceuticals Holdings logo

CRBP — Corbus Pharmaceuticals Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Corbus Pharmaceuticals Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary

* Corbus Pharmaceuticals Holdings Inc  CRBP.OQ  reported a
quarterly adjusted loss of $1.15​​ per share for the quarter
ended September 30, higher than the same quarter last year, when
the company reported EPS of $-2.05.  The mean expectation of
eight analysts for the quarter was for a loss of 95 cents per
share. Wall Street expected results to range from $-1.14 to -74
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Corbus Pharmaceuticals Holdings Inc's reported EPS for the
quarter was a loss of $1.15​.
    * The company reported a quarterly loss of $13.78 million.
    * Corbus Pharmaceuticals Holdings Inc shares had fallen
by 8.3%
this quarter and gained 213.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Corbus
Pharmaceuticals Holdings Inc is $62.50 
This summary was machine generated from LSEG data November 7 at
08:43 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.95          -1.15          Missed
 Jun. 30 2024      -1.19          -0.90          Beat
 Mar. 31 2024      -1.09          -0.83          Beat
 Dec. 31 2023      -2.36          -1.81          Beat

Recent news on Corbus Pharmaceuticals Holdings

See all news